No abstract

No abstract

Background: The main objective was to study the seroprevalence of anti-CMV and anti-Rubella antibodies in pregnant women of Luanda (Angola), identify the primary maternal infection during gestation and to evaluate the socio-demographic risk factors associated with CMV and Rubella virus infections. Methods: A prospective cross-sectional study was conducted from August 2016 to May 2017. Blood samples were collected and specific anti-CMV and anti-Rubella antibodies (IgG and IgM) were quantified by electrochemiluminescence (COBAS e411). Demographic and clinical data were collected by standardized questionnaire. Bivariate and multivariate logistic regression analysis was used to quantify the effect of clinical and obstetric risk factors on virus seroprevalence. The level of statistical significance was set as p<0.05, and Odds Ratio (OR) and 95% Confidence Intervals (95% CI) were computed. Results: The 396 pregnant women participated in the study aged from 15 to 47. Of the participants, 382 (96.5%) had anti-CMV IgG antibodies, 8 (2.0%) had anti-CMV IgG and IgM antibodies and 6 (1.5%) were seronegative. For Rubella virus, 347 (87.6%) were positive for anti-IgG, 4 (1.0%) positive for anti-IgG and IgM, and 45 (11.4%) were seronegative. The mean age of CMV positivity was 28.4 (SD ± 6.2) and for Rubella virus was 28.6 (SD ± 6.1). The multivariate logistic regression analysis has shown a significant association between Rubella virus infection and pregnant women without child (OR 2.673; CI: 1.026 - 7.007) and suffering spontaneous abortion (OR 3.232; CI: 1.192 - 7.952). In contrast, the level of schooling, residence, occupation, marital status, number of children in the household, basic sanitation, gestational age, history of miscarriages and hepatitis B were not significantly associated with the Rubella virus infection. Conclusions: Overall, this study showed that there is a high seroprevalence of anti-CMV and anti-Rubella antibodies in pregnant women in Luanda. Therefore, it is important a rapid and accurate diagnosis of CMV and Rubella infection in pregnant women to prevent congenital infections. Rubella vaccination should be offered to women non-immune to Rubella. Overall, it would be important to implement national screening for CMV, Rubella and other diseases linked to maternal and child health.

No abstract